Drug Industry Balks at Biden’s ‘Partisan Patent Heist’ Plan

The pharmaceutical industry is pushing back on a Biden administration plan for seizing patents behind high-cost drugs, calling it a threat to US standing in global competition and among a handful of bad policy moves under the president.

The Biden administration’s framework released this month for “marching in” on drug patents and licensing them out to create lower-cost products is the “latest in a series of harmful policies that will undermine US leadership around the world,” sending a “very clear message to American innovators—we no longer have your back,” said Steve Ubl, CEO of the drug industry group PhRMA, in ...